Ozempic, Zepbound, Wegovy, and other GLP-1 medications have transformed the way we lose weight. People who take them report life-changi ...
Guy's is one of the first hospitals in the country to roll out weight-loss jabs. But whilst millions across the ...
The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...
Hosted on MSN17h
‘Probably going to be the most prescribed drug’; The future of weight loss drugsDrugs like Ozempic, Wegovy and Mounjaro are changing the game for weight loss according to a University of Illinois professor ...
Korea Joongang Daily on MSN17h
Hanmi seeks to gain on Wegovy with its own weight-loss drugHanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press conference held in San Francisco, California, on Jan. 15. [LEE JAE-LIM] SAN ...
The weight-loss succession race is heating up. Here's how biopharma execs talked up those efforts at JPM this week.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Eli Lilly trims Q4 guidance but maintains optimism with promising drugs like Zepbound for sleep apnea and global launches ...
The podcast features Numerator Chief Economist Leo Feler, who talks about the potential impact of GLP-1 drugs like Ozempic ...
Pharmacy professor Nicole Albanese discusses the science behind drugs like Ozempic and Wegovy, their potential to treat other ...
Next to artificial intelligence, weight-loss drugs have been one of the biggest themes investors latched onto in 2024. Eli ...
On Tuesday, New York Governor Kathy Hochul announced a new initiative to expand access to healthcare coverage for popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback